Poland· PL-100193148
Altabactin
A bacitracin product containing bacitracinum + neomycinum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Bacitracin is registered in 6 of 19 countries.
Countries holding a registration under ATC D06AX05 (bacitracin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Bacitracin · ATC D06AX05
6 / 19 countries
- Belgiumprice
- Canada
- Germany
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Bacitracinum + Neomycinum
- Manufacturer
- Sandoz GmbH
- Country
- Poland (PL)
- ATC code
- D06AX05
- ATC class
- Bacitracin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990293711
- gtin05907626706338
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D06AX05
Bacitracin, as other registers publish it.
- United StatesAlways Save Bacitracin ZincTrifecta Pharmaceuticals USA LLC
- United StatesantibioticStrategic Sourcing Services LLC
- United StatesAntibioticTopco Associates LLC
- United StatesastoneaASTONEA LABS PRIVATE LIMITED
- NorwayBacimycinTeva B.V.
- CanadaBACITINPENDOPHARM DIVISION OF PHARMASCIENCE INC
- United StatesbacitracinH E B
- United StatesBacitracinBluePoint Laboratories
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Neobacitracine
- Bulgaria · Bacitracin Zinc+neomycin Sulphate Sandoz Gmbh
- Estonia · Baneocin
- Greece · Vioplex – T
- Croatia · Bivacyn
- Italy · Orobicin
- Luxembourg · Neobacitracine
- Malta · Vioplex – T
- Slovenia · Bivacyn
- Slovakia · Baneocin, Framykoin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3e3d4b4-8545-4a82-82a7-9ad1768a063c GET /v1/drugs/d3e3d4b4-8545-4a82-82a7-9ad1768a063c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(250 IU + 5000 IU)/g",
"packaging": "05909990293711 ¦ OTC ¦ 1733\n1 tuba 20 g\n05907626706338 ¦ OTC ¦ 119060\n1 tuba 5 g",
"substance": "Bacitracinum 250 IU/g + Neomycinum 5 mg",
"common_name": "Bacitracinum + Neomycinum",
"pl_product_id": "100193148",
"pozwolenie_nr": "02937",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about bacitracin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.